#AbbVie’s TNF inhibitor, #Humira, will face biosimilar competition in 2023 in #US and is expected to lose nearly 6.… https://t.co/1BgSahOfMe
#AbbVie’s TNF inhibitor, #Humira, will face biosimilar competition in 2023 in #US and is expected to lose nearly 6.… https://t.co/1BgSahOfMe